Pediatrix Medical Group (NYSE:MD) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Pediatrix Medical Group, Inc. (NYSE:MD) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.44 and traded as high as $14.00. Pediatrix Medical Group shares last traded at $13.91, with a volume of 288,192 shares changing hands.

Wall Street Analysts Forecast Growth

MD has been the subject of a number of recent research reports. Truist Financial decreased their price target on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Monday, January 6th. Macquarie initiated coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target on the stock. UBS Group increased their price target on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Jefferies Financial Group raised their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $16.25.

Pediatrix Medical Group Stock Down 0.1 %

The firm has a market cap of $1.19 billion, a P/E ratio of -4.54, a PEG ratio of 1.41 and a beta of 1.57. The firm’s 50-day moving average price is $13.93 and its 200 day moving average price is $12.44. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Insider Buying and Selling

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the sale, the director now owns 138,683 shares of the company’s stock, valued at $2,128,784.05. The trade was a 16.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $16.00, for a total transaction of $129,728.00. Following the sale, the executive vice president now owns 135,810 shares in the company, valued at $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Rubric Capital Management LP raised its holdings in shares of Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after acquiring an additional 125,000 shares in the last quarter. State Street Corp grew its stake in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after acquiring an additional 50,597 shares during the last quarter. Pacer Advisors Inc. bought a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at about $35,492,000. Geode Capital Management LLC increased its position in shares of Pediatrix Medical Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after purchasing an additional 45,155 shares during the period. Finally, Weiss Asset Management LP lifted its holdings in shares of Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after acquiring an additional 306,143 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.